Drug Study - Ranitidine

Posted by: Admin

To receive automatic updates of Nursing News, Nursing Care Plans, Case Studies and the much awaited November 2008 Nursing Board Exam Result: click Subscribe to NursingCrib.com by Email or via RSS. If you have other topics to discuss, make a post on our Nursing Crib Forum. Thanks for visiting and enjoy your stay!

by: ishi21, RN

Zantac, Zantac EFFERdose, Zantac GELdose, Zantac-75

Action:

Potent anti-ulcer drug that competitively and reversibly inhibits histamine action at H₂-receptor sites on parietal cells, thus blocking gastric acid secretion. Indirectly reduces pepsin secretion but appears to have minimal effect on fasting and postprandial serum gastrin concentrations or secretion of gastric intrinsic factor or mucus

Classifications:

GASTROINTESTINAL AGENT; ANTISECRETORY (H2-RECEPTOR ANTAGONIST)

Indication:

Short-term treatment of active duodenal ulcer; maintenance therapy for duodenal ulcer patient after healing of acute ulcer; treatment of gastroesophageal reflux disease; short-term treatment of active, benign gastric ulcer; treatment of pathologic GI hypersecretory conditions (e.g., Zollinger-Ellison syndrome, systemic mastocytosis, and postoperative hypersecretion); heartburn.

DOWNLOAD

_____________________________________________________________________________________________

• Drug Study - Losartan Potassium Cozaar Action: Angiotensin II receptor (type AT1) antagonist acts as a potent vasoconstrictor and primary vasoactive hormone of the renin–angiotensin–aldosterone system. Classifications: cardiovascular agent; angiotensin ii receptor antagonist; antihypertensive Indication: Hypertension Download
• Drug Study - Diazepam Action: Psychotherapeutic agent related to chlordiazepoxide; reportedly superior in antianxiety and anticonvulsant activity, with somewhat shorter duration of action. Like chlordiazepoxide, it appears to act at both limbic and subcortical levels of CNS. Classifications: CENTRAL NERVOUS SYSTEM AGENT; BENZODIAZEPINE ANTICONVULSANT; ANXIOLYTIC Indication: Drug of choice for status epilepticus. Management of anxiety disorders, for short-term relief of anxiety symptoms, to
• Drug Study - ATROPINE SULFATE Acts by selectively blocking all muscarinic responses to acetylcholine (ACh), whether excitatory or inhibitory. Selective depression of CNS relieves rigidity and tremor of Parkinson’s syndrome. Antisecretory action (vagolytic effect) suppresses sweating, lacrimation, salivation, and secretions from nose, mouth, pharynx, and bronchi. Blocks vagal impulses to heart with resulting decrease in AV conduction time, increase in
• Drug Study - Trimethoprim-Sulfamethoxazole (TMP-SMZ) Bactrim, Co-Trimoxazole, Septra Action: Fixed combination of sulfamethoxazole (SMZ), an intermediate acting antiinfective sulfonamide, and trimethoprim (TMP), a synthetic antiinfective. Both components of the combination are synthetic folate antagonist antiinfectives. Mechanism of action is principally enzyme inhibition, which prevents bacterial synthesis of essential nucleic acids and proteins. Classifications: antiinfective; urinary tract agent; sulfonamide Indication: Pneumocystis carinii pneumonitis, Shigellosis enteritis, and
• Drug Study - Furosemide Fumide , Furomide , Lasix, Luramide Action: Rapid-acting potent sulfonamide “loop” diuretic and antihypertensive with pharmacologic effects and uses almost identical to those of ethacrynic acid. Exact mode of action not clearly defined; decreases renal vascular resistance and may increase renal blood flow. Classification: ELECTROLYTIC AND WATER BALANCE AGENT; LOOP DIURETIC Indication: Treatment of edema associated with CHF, cirrhosis of liver,